-
Tolerogenic dendritic cells (a. k. a. tol-DCs, tDCs, or DCregs) are
heterogenous pool of
dendritic cells with immuno-suppressive properties,
priming immune...
-
Tolerogenic therapy aims to
induce immune tolerance where there is
pathological or
undesirable activation of the
normal immune response. This can occur...
-
resident DCs. BTLA is a
crucial molecule for DCs
mediated Treg conversion.
Tolerogenic DCs
express FasL and
TRAIL to
directly induce apoptosis of responding...
- well as
other less well-characterized
cells that help
establish a
local tolerogenic environment. B
cells also
express CD22, a non-specific
inhibitor receptor...
- self-peptide Ep1.B
derived from
apolipoprotein E.
These are
primarily tolerogenic plasmacytoid dendritic cells. In mice, it has been
estimated that dendritic...
- B-cells and
other immune effector cells on to the
target tissue. The
ideal tolerogenic therapy would target the
specific T-cell
clones co-ordinating the autoimmune...
-
reduce the risk of
autoimmunity and, subsequently, type 1 diabetes.
Tolerogenic therapies,
which s**** to
induce immune tolerance to beta-cell antigens...
- system's
production of
inflammatory cytokines are
suppressed and more
tolerogenic regulatory T-cells are expressed. This is due to
vitamin D's influence...
-
carry micronutrient. When β-lactoglobulin
carried micronutrient it
acted tolerogenic and
protected against allergy development. However, when the loading...
-
multiple external factors,
research suggests that a lack of
control by
tolerogenic dendritic cells and T-regulatory
cells (Treg) is
possibly the primary...
